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ETATE OF-THE-ART PAPER1287Cytokines and Growth Factors for Treating Ischemic Heart Diseaseirat Beohar, Jonathan Rapp, Sanjay Pandya, Douglas W. Losordo
ytokines influence angiogenesis directly via effects on endothelial cells or indirectly through
rogenitor cell-based mechanisms or by activating the expression of other angiogenic agents.
his paper by Beohar and colleagues reviews the clinical experience to date as well as the
uture potential of cytokine therapy for the treatment of ischemic heart disease. Currently, the
igh-quality studies that have been performed for agents, such as fibroblast growth factor,
ndothelial growth factor, and granulocyte colony-stimulating factor, have not reproduced the
fficacy observed in pre-clinical and small-scale clinical investigations. Nevertheless, the list of
romising cytokines continues to grow, and combinations of cytokines, with or without
oncurrent progenitor cell therapy, warrant further investigation.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY1298Mixed Results for Rheolytic Thrombectomy for AMIngela Migliorini, Amerigo Stabile, Alfredo E. Rodriguez, Caterina Gandolfo,
lfredo M. Rodriguez Granillo, Renato Valenti, Guido Parodi, Franz-Josef Neumann,
ntonio Colombo, David Antoniucci, on behalf of the JETSTENT Trial Investigators
igliorini and colleagues compared rheolytic thrombectomy (RT) with the AngioJet system
Medrad Interventional/Possis, Minneapolis, Minnesota) before stenting compared with direct
tenting (DS) alone for subjects with acute myocardial infarction (AMI). Eligible patients
ere those with AMI, angiographic evidence of significant thrombus, and a reference vessel
iameter 2.5 mm. The coprimary end points were early ST-segment resolution (STR) and
9mTc-sestamibi infarct size. There was no difference in infarct size. The results were almost
ignificant for STR, but there were significant reductions in major adverse cardiovascular
vents at 1 month, 6 months, and 1 year. Although the primary efficacy end points were not
et, the results suggest that RT may improve clinical outcomes.
ditorial Comment: Adnan Kastrati, Robert A. Byrne, Albert Schömig, p. 1307(continued on page A-20)
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tEART FAILURE
1310estosterone Supplementation Improves Walk Distance
and Muscle Strength in Women With CHFerdinando Iellamo, Maurizio Volterrani, Giuseppe Caminiti, Roger Karam, Rosalba Massaro,
assimo Fini, Peter Collins, Giuseppe M. C. Rosano
hronic heart failure (CHF) can lead to a metabolic shift favoring catabolism, and
mpairment in skeletal muscle bulk and function. Testosterone supplementation has shown
enefit in men with CHF, but this is the first report in women. A total of 36 elderly women
ith CHF (mean ejection fraction 33%) were randomized to 6 months of testosterone
upplementation or placebo. Distance walked during a 6-min walking test (6MWT)
ignificantly improved in the testosterone-treated subjects, as did peak VO2, with no change
n the placebo group. Muscle strength and insulin resistance also improved. Testosterone
upplementation improves functional capacity, insulin resistance, and muscle strength in
omen with advanced CHF; larger studies appear warranted.ditorial Comment: Paul W. Armstrong, Justin A. Ezekowitz, p. 1317EART RHYTHM DISORDERS
1320ffect of Epicardial Fat on Electroanatomical
Mapping and Epicardial Catheter Ablationenoit Desjardins, Fred Morady, Frank Bogun
esjardins and colleagues endeavored to correlate a 3-dimensional display of epicardial fat,
btained via a computed tomography (CT) scan, with the electroanatomical map obtained
uring a percutaneous epicardial mapping procedure to determine the relationship between
he two. In patients without cardiomyopathy, the low voltage area matched well with the area
f epicardial fat, with the thickness of epicardial fat correlating inversely with the epicardial
oltage. Epicardial ablations at sites with 10 mm of fat were ineffective. Cardiac CT
dentifies epicardial fat that can mimic scar tissue during epicardial voltage mapping and areas
hat are resistant to ablation.(continued on page A-24)
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tARDIAC STRESS TESTING1328Patterns of Cardiac Stress Testing After Revascularization Proceduresimal R. Shah, Patricia A. Cowper, Sean M. O’Brien, Neil Jensen, Matthew Drawz,
anesh R. Patel, Pamela S. Douglas, Eric D. Peterson
he routine use of stress testing within 2 years after revascularization is considered
inappropriate” by the American College of Cardiology Foundation’s appropriate use criteria.
hah and colleagues used data from a large insurance company of almost 30,000 patients who
nderwent revascularization (three-quarters percutaneous coronary intervention) to estimate
ow many had undergone an “inappropriate” stress test. A total of 59% had at least 1 cardiac
tress test within the next 24 months after revascularization. Of those tested, only 11% had a
ubsequent cardiac catheterization and only 5% had repeat revascularization. These results
uggest that many patients undergo routine stress testing after revascularization and that it
arely leads to further revascularization.ditorial Comment: George A. Beller, p. 1335YPERTENSION1338Genetic Variation in Gene for CHGB Linked to Oxidative Stress and Hypertensionangwen Rao, Kuixing Zhang, Srikrishna Khandrika, Manjula Mahata, Maple M. Fung,
ichael G. Ziegler, Brinda K. Rana, Daniel T. O’Connor
ao and colleagues studied twins to identify genetic factors associated with hypertension.
rinary isoprostane excretion, a marker of oxidative stress, was found to be highly heritable
nd to segregate with multiple traits including hypertension, chromogranin B (CHGB) levels,
nd several features of the metabolic syndrome. A variant in the 3=-untranslated region of
HGB predicted plasma CHGB as well as isoprostane excretion. Further studies confirmed
hat this region of the gene is necessary for efficient translation. The authors propose a model
herein this genetic variant for CHGB results in unregulated catecholamine release, which
riggers increased oxidative stress and eventually systemic hypertension.
